Zacks Investment Research upgraded shares of Landauer, Inc. (NYSE:LDR) from a hold rating to a strong-buy rating in a report issued on Tuesday morning. Zacks Investment Research currently has $72.00 price objective on the scientific and technical instruments company’s stock.
According to Zacks, “Landauer Inc. is the world’s leading provider of analytical services to determine occupational and environmental radiation exposure. For more than fifty years, the company has provided complete radiation dosimetry services to hospitals, medical and dental offices, universities, national laboratories, and other industries in which radiation poses a potential threat to employees. Landauer’s services include the manufacture of various types of radiation detection monitors, the distribution and collection of the monitors to and from clients, and the analysis and reporting of exposure findings. The company provides its services to one.five million people in the United States, Japan, France, the United Kingdom, Brazil, Canada, China, Australia and other countries. “
Separately, BidaskClub upgraded shares of Landauer from a strong sell rating to a sell rating in a research note on Wednesday, August 9th.
Shares of Landauer (NYSE:LDR) opened at 60.25 on Tuesday. Landauer has a 52-week low of $41.00 and a 52-week high of $62.85. The stock has a market cap of $580.69 million, a P/E ratio of 31.20 and a beta of 1.30. The firm’s 50-day moving average price is $56.20 and its 200-day moving average price is $52.37.
Landauer (NYSE:LDR) last announced its earnings results on Tuesday, August 8th. The scientific and technical instruments company reported $0.67 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.49 by $0.18. The firm had revenue of $39.89 million for the quarter. Landauer had a net margin of 12.09% and a return on equity of 80.03%. Equities analysts predict that Landauer will post $1.92 EPS for the current year.
COPYRIGHT VIOLATION WARNING: “Landauer, Inc. (LDR) Upgraded to “Strong-Buy” by Zacks Investment Research” was originally reported by BNB Daily and is the property of of BNB Daily. If you are reading this piece of content on another website, it was copied illegally and republished in violation of U.S. & international copyright and trademark law. The original version of this piece of content can be viewed at https://www.baseball-news-blog.com/2017/08/19/landauer-inc-ldr-upgraded-to-strong-buy-by-zacks-investment-research.html.
Several institutional investors have recently added to or reduced their stakes in the stock. Mason Street Advisors LLC increased its position in Landauer by 7.2% in the first quarter. Mason Street Advisors LLC now owns 2,250 shares of the scientific and technical instruments company’s stock worth $110,000 after buying an additional 151 shares in the last quarter. BNP Paribas Arbitrage SA increased its position in Landauer by 55.1% in the second quarter. BNP Paribas Arbitrage SA now owns 3,112 shares of the scientific and technical instruments company’s stock worth $163,000 after buying an additional 1,106 shares in the last quarter. Smith Asset Management Group LP acquired a new position in Landauer during the second quarter worth about $179,000. Louisiana State Employees Retirement System acquired a new position in Landauer during the second quarter worth about $204,000. Finally, OxFORD Asset Management LLP acquired a new position in Landauer during the second quarter worth about $218,000. Hedge funds and other institutional investors own 81.42% of the company’s stock.
Landauer Company Profile
Landauer, Inc is a provider of technical and analytical services to determine occupational and environmental radiation exposure. The Company is a provider of outsourced medical physics services, and a provider of radiology related medical products. The Company operates through three segments: Radiation Measurement, Medical Physics and Medical Products.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Landauer Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Landauer Inc. and related companies with MarketBeat.com's FREE daily email newsletter.